Etienne Chuffart1, Maxime Sodji2, François Dalmay3, Antonio Iannelli4, Muriel Mathonnet5. 1. Department of Digestive Surgery, CHU of Limoges, 2 av Martin Luther King, 87042, Limoges, France. 2. Bariatric Surgery, Clinique F Chénieux, 18 rue du Général Catroux, 87000, Limoges, France. 3. CEBIMER, Faculté de Médecine de Limoges, 2 rue du Dr Marcland, 87042, Limoges, France. 4. Hôpital de l'Archet, Pôle Digestif, Centre Hospitalier Universitaire de Nice, 06202, Nice, France. 5. Department of Digestive Surgery, CHU of Limoges, 2 av Martin Luther King, 87042, Limoges, France. mathonnet@unilim.fr.
Abstract
BACKGROUND: Many studies have analyzed the impact of sleeve gastrectomy (SG) on weight loss and/or the evolution of obesity-related comorbid conditions, but few have reported the long-term outcomes after surgery. The objective of this study was to investigate the outcomes after SG on weight loss, obesity-related comorbid conditions, quality of life (QoL), and GERD symptoms (GERDS) beyond 5 years. METHODS: A prospective database was retrospectively searched for the following factors: gender, age, anthropometrics, presence of comorbid conditions, QoL (BAROS questionnaire), and presence of GERDS. The data were analyzed before and at 1 and 6 years after surgery. RESULTS: Of the 64 patients included, 32.8% were lost to follow-up (76% during the first postoperative year). A complete follow-up of >5 years was obtained for 41 patients. Before surgery, mean excess BMI was 22 ± 7 kg/m2, and 26.8% of patients had GERDS. Percent excess BMI loss was 55 ± 30% at 1 year and 48 ± 27% at 6 years. Preoperative BMI and absence of type 2 diabetes (T2D) before surgery were the only independent variables for long-term failure. Six years after SG, remission from metabolic comorbidities was as follows: 50% for T2D, 28% for blood hypertension, 58% for dyslipidemia, and 33% for sleep-apnea syndrome. Thirty percent of patients with preoperative GERD had resolution of symptoms at 6 years whereas 9 patients (32%) had de novo GERD. QoL was improved for 62% of patients at 6 years. CONCLUSION: The benefits of SG on weight loss, resolution of comorbidities, and QoL were maintained in the long term for most patients.
BACKGROUND: Many studies have analyzed the impact of sleeve gastrectomy (SG) on weight loss and/or the evolution of obesity-related comorbid conditions, but few have reported the long-term outcomes after surgery. The objective of this study was to investigate the outcomes after SG on weight loss, obesity-related comorbid conditions, quality of life (QoL), and GERD symptoms (GERDS) beyond 5 years. METHODS: A prospective database was retrospectively searched for the following factors: gender, age, anthropometrics, presence of comorbid conditions, QoL (BAROS questionnaire), and presence of GERDS. The data were analyzed before and at 1 and 6 years after surgery. RESULTS: Of the 64 patients included, 32.8% were lost to follow-up (76% during the first postoperative year). A complete follow-up of >5 years was obtained for 41 patients. Before surgery, mean excess BMI was 22 ± 7 kg/m2, and 26.8% of patients had GERDS. Percent excess BMI loss was 55 ± 30% at 1 year and 48 ± 27% at 6 years. Preoperative BMI and absence of type 2 diabetes (T2D) before surgery were the only independent variables for long-term failure. Six years after SG, remission from metabolic comorbidities was as follows: 50% for T2D, 28% for blood hypertension, 58% for dyslipidemia, and 33% for sleep-apnea syndrome. Thirty percent of patients with preoperative GERD had resolution of symptoms at 6 years whereas 9 patients (32%) had de novo GERD. QoL was improved for 62% of patients at 6 years. CONCLUSION: The benefits of SG on weight loss, resolution of comorbidities, and QoL were maintained in the long term for most patients.
Entities:
Keywords:
GERD; Long-term results; Obesity; Quality of life; Sleeve gastrectomy
Authors: Ali Aminian; Stacy A Brethauer; Amin Andalib; Suriya Punchai; Jennifer Mackey; John Rodriguez; Tomasz Rogula; Matthew Kroh; Philip R Schauer Journal: Ann Surg Date: 2016-10 Impact factor: 12.969
Authors: Gary Whitlock; Sarah Lewington; Paul Sherliker; Robert Clarke; Jonathan Emberson; Jim Halsey; Nawab Qizilbash; Rory Collins; Richard Peto Journal: Lancet Date: 2009-03-18 Impact factor: 79.321
Authors: Daniel M Felsenreich; Lukas M Ladinig; Philipp Beckerhinn; Christoph Sperker; Katrin Schwameis; Michael Krebs; Julia Jedamzik; Magdalena Eilenberg; Christoph Bichler; Gerhard Prager; Felix B Langer Journal: Obes Surg Date: 2018-11 Impact factor: 4.129
Authors: Abdel-Naser Elzouki; Muhammad-Aamir Waheed; Salah Suwileh; Islam Elzouki; Hisham Swehli; Maryam Alhitmi; Mona Saad; Elmukhtar Habas; Suhail A Doi; Mohammed I Danjuma Journal: Surg Open Sci Date: 2021-11-19
Authors: Eyup Gemici; Osman Kones; Hakan Seyit; Ahmet Surek; Murat Cikot; Mehmet Abdussamet Bozkurt; Halil Alis Journal: Wideochir Inne Tech Maloinwazyjne Date: 2019-02-25 Impact factor: 1.195